
Catherine R. Oliver-garcia
Examiner (ID: 9259, Phone: (571)272-2655 , Office: P/2914 )
| Most Active Art Unit | 2914 |
| Art Unit(s) | 2904, 2900, 2914 |
| Total Applications | 7479 |
| Issued Applications | 7429 |
| Pending Applications | 0 |
| Abandoned Applications | 54 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6765589
[patent_doc_number] => 20030099988
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-29
[patent_title] => 'Novel Human tumor suppressor'
[patent_app_type] => new
[patent_app_number] => 10/243815
[patent_app_country] => US
[patent_app_date] => 2002-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 17426
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20030099988.pdf
[firstpage_image] =>[orig_patent_app_number] => 10243815
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/243815 | Novel Human tumor suppressor | Sep 12, 2002 | Abandoned |
Array
(
[id] => 6750314
[patent_doc_number] => 20030044834
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-06
[patent_title] => 'GDU, a novel signalling protein'
[patent_app_type] => new
[patent_app_number] => 10/242332
[patent_app_country] => US
[patent_app_date] => 2002-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3174
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20030044834.pdf
[firstpage_image] =>[orig_patent_app_number] => 10242332
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/242332 | GDU, a novel signalling protein | Sep 10, 2002 | Abandoned |
| 60/509052 | Methods of modulating cell death based on the Bit-1/AES regulatory pathway | Sep 5, 2002 | Pending |
| 60/509048 | Collagen-binding molecules that selectively home to tumor vasculature and methods of using same | Aug 27, 2002 | Pending |
Array
(
[id] => 6861615
[patent_doc_number] => 20030092623
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-15
[patent_title] => 'Bv8 nucleic acids and polypeptides with mitogenic activity'
[patent_app_type] => new
[patent_app_number] => 10/231411
[patent_app_country] => US
[patent_app_date] => 2002-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 33191
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20030092623.pdf
[firstpage_image] =>[orig_patent_app_number] => 10231411
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/231411 | Bv8 nucleic acids and polypeptides with mitogenic activity | Aug 26, 2002 | Issued |
Array
(
[id] => 7314252
[patent_doc_number] => 20040033974
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-19
[patent_title] => 'Use of genes identified to be involved in tumor development for the development of anti-cancer drugs'
[patent_app_type] => new
[patent_app_number] => 10/224524
[patent_app_country] => US
[patent_app_date] => 2002-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6219
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0033/20040033974.pdf
[firstpage_image] =>[orig_patent_app_number] => 10224524
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/224524 | Use of genes identified to be involved in tumor development for the development of anti-cancer drugs | Aug 18, 2002 | Abandoned |
Array
(
[id] => 7312983
[patent_doc_number] => 20040033495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-19
[patent_title] => 'Methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators'
[patent_app_type] => new
[patent_app_number] => 10/211462
[patent_app_country] => US
[patent_app_date] => 2002-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 145129
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0033/20040033495.pdf
[firstpage_image] =>[orig_patent_app_number] => 10211462
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/211462 | Methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators | Jul 31, 2002 | Abandoned |
Array
(
[id] => 6674281
[patent_doc_number] => 20030059884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-27
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/200617
[patent_app_country] => US
[patent_app_date] => 2002-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 616
[patent_figures_cnt] => 616
[patent_no_of_words] => 61099
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20030059884.pdf
[firstpage_image] =>[orig_patent_app_number] => 10200617
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/200617 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Jul 17, 2002 | Abandoned |
Array
(
[id] => 6750343
[patent_doc_number] => 20030044863
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-06
[patent_title] => 'Invasion complex and methods of targeting'
[patent_app_type] => new
[patent_app_number] => 10/197725
[patent_app_country] => US
[patent_app_date] => 2002-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5897
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20030044863.pdf
[firstpage_image] =>[orig_patent_app_number] => 10197725
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/197725 | Invasion complex and methods of targeting | Jul 17, 2002 | Abandoned |
Array
(
[id] => 6783008
[patent_doc_number] => 20030064455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-03
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/198766
[patent_app_country] => US
[patent_app_date] => 2002-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 616
[patent_figures_cnt] => 616
[patent_no_of_words] => 61096
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20030064455.pdf
[firstpage_image] =>[orig_patent_app_number] => 10198766
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/198766 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Jul 17, 2002 | Abandoned |
Array
(
[id] => 7362598
[patent_doc_number] => 20040005313
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-08
[patent_title] => ' Use of specified TCF target genes to identify drugs for the treatment of cancer, in particular colorectal cancer, in which TCF/beta-catenin/WNT signalling plays a central role'
[patent_app_type] => new
[patent_app_number] => 10/197619
[patent_app_country] => US
[patent_app_date] => 2002-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7044
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0005/20040005313.pdf
[firstpage_image] =>[orig_patent_app_number] => 10197619
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/197619 | Use of specified TCF target genes to identify drugs for the treatment of cancer, in particular colorectal cancer, in which TCF/beta-catenin/WNT signalling plays a central role | Jul 15, 2002 | Abandoned |
Array
(
[id] => 6846323
[patent_doc_number] => 20030165490
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => '22196, a novel human aminopeptidase'
[patent_app_type] => new
[patent_app_number] => 10/192207
[patent_app_country] => US
[patent_app_date] => 2002-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 31368
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20030165490.pdf
[firstpage_image] =>[orig_patent_app_number] => 10192207
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/192207 | 22196, a novel human aminopeptidase | Jul 9, 2002 | Abandoned |
Array
(
[id] => 6846324
[patent_doc_number] => 20030165491
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => '22196, a novel human aminopeptidase'
[patent_app_type] => new
[patent_app_number] => 10/192445
[patent_app_country] => US
[patent_app_date] => 2002-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 31371
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20030165491.pdf
[firstpage_image] =>[orig_patent_app_number] => 10192445
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/192445 | 22196, a novel human aminopeptidase | Jul 9, 2002 | Abandoned |
Array
(
[id] => 6829760
[patent_doc_number] => 20030180818
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-25
[patent_title] => 'Peptidoglycan recognition proteins'
[patent_app_type] => new
[patent_app_number] => 10/180454
[patent_app_country] => US
[patent_app_date] => 2002-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 68580
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 158
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20030180818.pdf
[firstpage_image] =>[orig_patent_app_number] => 10180454
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/180454 | Peptidoglycan recognition proteins | Jun 26, 2002 | Issued |
Array
(
[id] => 6688402
[patent_doc_number] => 20030032127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-13
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/183012
[patent_app_country] => US
[patent_app_date] => 2002-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 616
[patent_figures_cnt] => 616
[patent_no_of_words] => 57321
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20030032127.pdf
[firstpage_image] =>[orig_patent_app_number] => 10183012
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/183012 | PRO1305-polypeptides | Jun 25, 2002 | Issued |
Array
(
[id] => 122097
[patent_doc_number] => 07709602
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-04
[patent_title] => 'PRO1078 polypeptides'
[patent_app_type] => utility
[patent_app_number] => 10/176754
[patent_app_country] => US
[patent_app_date] => 2002-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 615
[patent_figures_cnt] => 615
[patent_no_of_words] => 56508
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/709/07709602.pdf
[firstpage_image] =>[orig_patent_app_number] => 10176754
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/176754 | PRO1078 polypeptides | Jun 19, 2002 | Issued |
Array
(
[id] => 6715919
[patent_doc_number] => 20030027267
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-06
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/175739
[patent_app_country] => US
[patent_app_date] => 2002-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 616
[patent_figures_cnt] => 616
[patent_no_of_words] => 57305
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20030027267.pdf
[firstpage_image] =>[orig_patent_app_number] => 10175739
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/175739 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Jun 18, 2002 | Abandoned |
Array
(
[id] => 6813622
[patent_doc_number] => 20030073172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-17
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/175750
[patent_app_country] => US
[patent_app_date] => 2002-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 616
[patent_figures_cnt] => 616
[patent_no_of_words] => 57323
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20030073172.pdf
[firstpage_image] =>[orig_patent_app_number] => 10175750
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/175750 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Jun 18, 2002 | Abandoned |
Array
(
[id] => 7382672
[patent_doc_number] => 20040029220
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-12
[patent_title] => 'Novel proteins and nucleic acids encoding same'
[patent_app_type] => new
[patent_app_number] => 10/174333
[patent_app_country] => US
[patent_app_date] => 2002-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 83681
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20040029220.pdf
[firstpage_image] =>[orig_patent_app_number] => 10174333
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/174333 | Novel proteins and nucleic acids encoding same | Jun 17, 2002 | Abandoned |
Array
(
[id] => 7679172
[patent_doc_number] => 20030167480
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'NDR2-related proteins'
[patent_app_type] => new
[patent_app_number] => 10/172069
[patent_app_country] => US
[patent_app_date] => 2002-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 17438
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20030167480.pdf
[firstpage_image] =>[orig_patent_app_number] => 10172069
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/172069 | NDR2-related proteins | Jun 12, 2002 | Abandoned |